Western Alliance Bancorporation Announces Second Quarter 2025 Earnings Release Date, Conference Call and Webcast
Participants may access the call by dialing 1-833-470-1428 using the access code 863006 or via live audio webcast using the website link: https://events.q4inc.com/attendee/646018783.
The webcast is also available through the Company's website at www.westernalliancebancorporation.com. Participants should log in at least 15 minutes early to receive instructions. The call will be recorded and made available for replay July 18 th after 3:00 p.m. ET until July 25 th at 11:59 p.m. ET by dialing 1-866-813-9403 using the access code: 760564.
About Western Alliance Bancorporation
With more than $80 billion in assets, Western Alliance Bancorporation (NYSE:WAL) is one of the country's top-performing banking companies. Through its primary subsidiary, Western Alliance Bank, Member FDIC, clients benefit from a full spectrum of tailored commercial banking solutions and consumer products, all delivered with outstanding service by industry experts who put customers first. Major accolades include being ranked as a top U.S. bank in 2024 by American Banker and Bank Director and receiving #1 rankings on Extel's (formerly Institutional Investor's) All-America Executive Team Midcap Banks 2024 for Best CEO, Best CFO and Best Company Board of Directors. Serving clients across the country wherever business happens, Western Alliance Bank operates individual, full-service banking and financial brands with offices in key markets nationwide. For more information, visit Western Alliance Bancorporation.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
41 minutes ago
- CTV News
CTV National News: How Trump is justifying a tariff on imported copper
Watch Donald Trump says a 50 per cent tariff on imported copper will come into effect as of Aug. 1, citing national security concerns. Mike Le Couteur has more.
CTV News
an hour ago
- CTV News
Windsor metal shop owner bracing for possible Trump tariff on copper exports
At RJ Steel Co., Ryan Jordan and his staff shifted focus to copper to avoid steel tariffs. Now that metal faces a potential tariff of its own. (Travis Fortnum/CTV News Windsor) Just minutes from the U.S. border, a Windsor metal fabricator says he's anxiously watching trade developments that could hit his bottom line. Ryan Jordan, owner of RJ Steel Co., ships fabricated copper, steel and aluminum products across the border — with about 15 to 20 per cent of his revenue tied to U.S. clients. 'I spoke with one customer today who says, 'What's this mean about your price now? Is this price that you've provided us a month ago — does that still stand?' And I said, I do not know. I do not know at this point,' said Jordan. In 2018, when President Donald Trump first imposed tariffs on imported steel and aluminum, Jordan pivoted his operations — investing more in copper fabrication, which wasn't targeted at the time. 'It was a good fit for us,' he said. 'It allowed us to put money towards something that wouldn't affect us with the tariffs. And copper was not tariffed at the time.' Now, it could be. Trump, who is in office again, announced this week that he plans to impose a 50 per cent tariff on imported copper. Wednesday evening he said that would be in place August 1. 'I'm as nervous as I was in 2018,' said Jordan. Industry Minister Melanie Joly addressed the matter Wednesday morning, saying no formal order had yet been issued. 'When it comes to the latest declaration from the President in the United States, we have not yet seen an executive order,' she said. Canada exported $9.3 billion worth of copper in 2023 — with 52 per cent of that going to the U.S. Joly said the federal government's priority is protecting Canadian jobs and businesses from what she called 'unjustifiable and unjustified tariffs.' 'My job right now is to make sure that in the context of this trade war, I'm supporting the front lines of this trade war, which are the workers and the companies affected,' she said. Jordan said the uncertainty alone could put local businesses like his at a disadvantage. 'In a competitive atmosphere or a competitive market, you're going to find that every dollar counts,' he said.
National Post
an hour ago
- National Post
Canadian pharmaceutical industry alarmed after Trump threatens 200% tariff on drug imports
WASHINGTON — Canada likely isn't the main target of U.S. President Donald Trump's threat to impose a 200 per cent tariff on pharmaceutical imports, an industry representative said Wednesday — but his plan could still put parts of the Canadian sector in peril. Article content 'Canada is not the target but we could get caught in the crossfire if there are broad-based tariffs on pharmaceuticals,' said Canadian Generic Pharmaceutical Association president Jim Keon. Article content Article content On Tuesday, Trump floated the idea of massive pharmaceutical tariffs but said he would give drug makers up to a year and a half before introducing the duties. Article content Article content Trump launched an investigation under Section 232 of the Trade Expansion Act of 1962 into pharmaceuticals in April, claiming national security concerns linked to America's reliance on imported drugs. A lot of those imported drugs come from China and India. Article content A report on that investigation has not been released but Commerce Secretary Howard Lutnick told CNBC Tuesday that details about pharmaceutical duties would come out at the end of the month. Article content Generic medicines are used to fill about 90 per cent of all prescriptions in the United States. Canadian exports amount to less than five per cent of all generic medicines sold in the U.S., Keon said. Article content Such a low volume shouldn't trigger any U.S. concerns about an overreliance on imports, Keon said. Article content He said there is hope that the economic and security agreement being negotiated between Canada and the United States will ensure pharmaceuticals remain tariff-free. Ottawa and the Trump administration have set a July 21 target to finalize the deal. Article content Article content 'We have learned over the last six to eight months not to overreact to the statements and wait and see what actually comes out in the executive order in the tariffs themselves,' Keon said. Article content Article content But if Canada is not spared from the looming pharmaceutical duties, Keon said, that would have impacts for Canadian and foreign companies that manufacture drugs in this country. Article content Generic pharmaceuticals have a low profit margin. Without access to the American market, Keon said, it might not be practical for some companies in Canada to continue producing certain generic medicines for the domestic market. Article content 'I think as a Canadian industry and as part of a global industry, we've been operating without tariffs for the last several decades and imposing tariffs is going to increase costs and complicate supply chains,' Keon said.
